- Home
- AZEK vs JAZZ Comparison
AZEK vs JAZZ Comparison
Compare AZEK & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZEK
- JAZZ
- Stock Information
- Founded
- AZEK 2013
- JAZZ 2003
- Country
- AZEK United States
- JAZZ Ireland
- Employees
- AZEK N/A
- JAZZ N/A
- Industry
- AZEK Plastic Products
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- AZEK Industrials
- JAZZ Health Care
- Exchange
- AZEK Nasdaq
- JAZZ Nasdaq
- Market Cap
- AZEK 6.8B
- JAZZ 6.1B
- IPO Year
- AZEK 2020
- JAZZ 2007
- Fundamental
- Price
- AZEK $50.14
- JAZZ $98.33
- Analyst Decision
- AZEK Buy
- JAZZ Strong Buy
- Analyst Count
- AZEK 16
- JAZZ 13
- Target Price
- AZEK $54.11
- JAZZ $181.85
- AVG Volume (30 Days)
- AZEK 2.7M
- JAZZ 1.4M
- Earning Date
- AZEK 05-06-2025
- JAZZ 05-06-2025
- Dividend Yield
- AZEK N/A
- JAZZ N/A
- EPS Growth
- AZEK 3.06
- JAZZ 48.99
- EPS
- AZEK 1.03
- JAZZ 7.51
- Revenue
- AZEK $1,520,256,000.00
- JAZZ $4,064,808,000.00
- Revenue This Year
- AZEK $9.47
- JAZZ $7.60
- Revenue Next Year
- AZEK $8.37
- JAZZ $3.47
- P/E Ratio
- AZEK $48.42
- JAZZ $13.11
- Revenue Growth
- AZEK 5.92
- JAZZ 5.76
- 52 Week Low
- AZEK $35.48
- JAZZ $95.49
- 52 Week High
- AZEK $54.91
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- AZEK 59.94
- JAZZ 33.78
- Support Level
- AZEK $48.71
- JAZZ $97.50
- Resistance Level
- AZEK $50.91
- JAZZ $120.67
- Average True Range (ATR)
- AZEK 0.85
- JAZZ 4.27
- MACD
- AZEK 0.05
- JAZZ -0.48
- Stochastic Oscillator
- AZEK 81.42
- JAZZ 4.75
About AZEK The AZEK Company Inc.
The AZEK Co Inc is a designer and manufacturer of beautiful, low maintenance and environmentally sustainable products focused on the fast-growing Outdoor Living market. Its portfolio of products includes decks, rail, trim, outdoor furniture among others. The company operates in two segments: Residential Segment that manufactures and distributes decking, railing, trim, moulding, pergolas and cabanas and accessories through a national network of dealers and distributors and multiple home improvement retailers; and Commercial Segment that manufactures, fabricates and distributes lockers and bathroom partitions. It generates maximum revenue from the Residential segment. The company's brand includes TimberTech; AZEK; Versatex, Ultralox, StruXure, and Intex.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.